Clinical trial
Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study
NCT04724278
Study timeline
Study start (actual)2021-02-05Date precision: day
Registry last updated2021-06-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaverified · MONDO: asthma
Interventions
Sponsors & collaborators
National Jewish Healthlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04724278 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.